There is still a place for optimised thiopurine therapy in IBD

Saved in:
Bibliographic Details
Published inGut Vol. 70; no. 11; p. 2207
Main Authors Crouwel, Femke, Buiter, Hans J C, de Boer, Nanne K H
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group Ltd and British Society of Gastroenterology 01.11.2021
BMJ Publishing Group LTD
Subjects
6-Mercaptopurine
Allopurinol
azathioprine
Azathioprine - therapeutic use
Crohn Disease - drug therapy
Crohn's disease
Drug withdrawal
Gastroenterology
Genotyping
Humans
Hydrolase
Immunogenicity
Inflammatory bowel disease
Mercaptopurine - therapeutic use
Methyltransferase
Myelosuppression
Pancreatitis
Patients
PostScript
Reintroduction
Remission
Remission (Medicine)
Response rates
Systematic review
Thioguanine
Thiopurine S-methyltransferase
Tumor necrosis factor
ulcerative colitis
azathioprine
Crohn's disease
ulcerative colitis
6-mercaptopurine
inflammatory bowel disease
Online AccessGet full text

Cover

More Information
Bibliography:Letter
SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
ISSN:0017-5749
1468-3288
DOI:10.1136/gutjnl-2020-323481